Konstantina Katcheves, Senior VP of Innovative Global Business Development at Teva Pharmaceuticals brings insights from the World Economic Forum to SCOPE 2025.
In this discussion, Konstantina Katcheves, senior VP of innovative global business development at Teva Pharmaceuticals discusses her takeaways from her time at the World Economic Forum (WEF). She stresses the importance of data-driven healthcare and AI innovation in the pharmaceutical value chain, and the critical need to address global health equity, particularly women’s health. Within the conversation, Katcheves also addresses the industry’s challenge in regaining patient trust, suggesting that empowering patients to use their data for health decisions could improve trust.
Key Takeaways
- There is a gap in global health equity, particularly in women’s health, and the critical role of women in healthcare decisions was emphasized.
- The life sciences industry in the US is expected to continue leading initiatives related to diversity, inclusion, and women’s health.
- Building patient trust in data management and usage is a key challenge for the industry.
- The industry is struggling with public engagement, but emerging technologies can help break down barriers and improve outreach efforts.
ALL COVERAGE
Jay Ferro, EVP, CIO, CPO & CTO at Clario discusses safety, trust and what keeps him up at night.
Continuing our SCOPE 2025 coverage, Rohit Nambisan, CEO at Lokavant addresses not only current challenges, but the life sciences industry’s responsibility to maintain scientific integrity.
Elisa Cascade, CPO at Advarra explains why addressing the challenges faced by clinical research sites is vital for improving patient trust and the overall viability of clinical trials.
The industry remains unwavering in the commitment to increased clinical trial accessibility and representation.
As communication gaps in the US healthcare market widen, the emphasis on the need for credible information and patient empowerment is paramount.
While at SCOPE 2025, Sam Srivastava, CEO at WCG Clinical discusses the challenges and responsibilities of the life sciences industry in building public trust amidst growing anger towards healthcare.
In the current legal and political landscape, it is all about survival for DEI initiatives.
Konstantina Katcheves, Senior VP of Innovative Global Business Development at Teva Pharmaceuticals brings insights from the World Economic Forum to SCOPE 2025.
